SCHEMBL8906971

SCHEMBL8906971

CCOC(=O)C(N)CC(Cc1ccc(OC)c(OCCCOC)c1)C(C)C

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14538630 1.00 REN (0.62) REN
SCHEMBL8906976 1.00 REN (0.62) REN
SCHEMBL3752538 0.92 REN (0.64) REN
SCHEMBL3752535 0.92 REN (0.64) REN
SCHEMBL8267544 0.89 REN (0.62) REN
SCHEMBL27975141 0.89 REN (0.62) REN
SCHEMBL3759583 0.88 REN (0.59) REN
SCHEMBL3759588 0.88 REN (0.59) REN
SCHEMBL17770770 0.84 REN (0.61) REN
SCHEMBL14777723 0.83 REN (0.53) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5659065-A CHEMICAL INTERMEDIATES FOR MEDICINAL ACTIVE AGENTS NOVARTIS CORPORATION (US) 1997-08-19 US claimed
JP-8027079-A None JP disclosed
US-5659065-A CHEMICAL INTERMEDIATES FOR MEDICINAL ACTIVE AGENTS NOVARTIS CORPORATION (US) 1997-08-19 US disclosed
JP-H0827079-A ALPHA-AMINOALKANOIC ACID AND REDUCTION PRODUCT CIBA GEIGY AG 1996-01-30 JP disclosed